Vaxcyte, Inc. (NASDAQ:PCVX) Given Average Rating of Buy by Analysts

Shares of Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) have earned a consensus rating of “Buy” from the six ratings firms that are covering the firm, MarketBeat Ratings reports. Six research analysts have rated the stock with a buy rating. The average 12-month price target among analysts that have covered the stock in the last […]

Related Keywords

Mizuho ,Sakhalinskaya Oblast ,Russia ,United States ,America ,Andrew Guggenhime ,Mikhail Eydelman ,Daiwa Securities Group Inc ,Needham Company ,Securities Exchange Commission ,Nasdaq ,Avior Wealth Management ,First Horizon Advisors Inc ,Groupa Streptococcus ,Cantor Fitzgerald ,Vaxcyte Inc ,Russell Investments Group Ltd ,Wells Fargo Company ,Get Free Report ,Marketbeat Ratings ,Trading Down ,Exchange Commission ,Horizon Advisors ,Investments Group ,Wealth Management ,Securities Group ,Wells Fargo ,Get Free ,Vaxcyte Daily ,Vaxcyte ,Nasdaq Pcvx ,Pcvx ,Medical ,Ratings ,Consensus ,